Adhesion molecules as targets for the treatment of autoimmune diseases.
Oppenheimer-Marks
N
N
Simmons Arthritis Research Center, Department of Internal Medicine, University of Texas, Southwestern Medical Center at Dallas, Texas 75235-8884, USA.
Lipsky
P E
PE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000628:therapy*; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000502:physiology*; D002465:Cell Movement; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D007136:Immunoglobulins / Q000737:chemistry; D007249:Inflammation / Q000276:immunology / Q000473:pathology; D016023:Integrins / Q000502:physiology; D019087:Selectins / Q000502:physiology; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015815:Cell Adhesion Molecules; D007136:Immunoglobulins; D016023:Integrins; D019087:Selectins